Data | Method | EPSO | BPSO | ||||
---|---|---|---|---|---|---|---|
 | Evaluation | Best | #Ave | S.D | Best | #Ave | S.D |
11_Tumors | #Acc (%) | 96.55 | 95.40 | 0.61 | 97.7 | 96.78 | 0.73 |
#Genes | 243 | 237.70 | 9.66 | 230 | 221.30 | 14.48 | |
#Time | 67.21 | 67.05 | 0.22 | 212.44 | 252.05 | 32.87 | |
9_Tumors | #Acc (%) | 76.67 | 75.00 | 1.11 | 85 | 82.67 | 2.25 |
#Genes | 251 | 247.10 | 9.65 | 250 | 244.30 | 9.43 | |
#Time | 4.35 | 4.29 | 0.09 | 17.97 | 17.74 | 0.10 | |
Brain_Tumor1 | #Acc (%) | 93.33 | 92.11 | 0.82 | 93.33 | 92.44 | 0.47 |
#Genes | 8 | 7.5 | 2.51 | 217 | 215 | 7.24 | |
#Time | 14.89 | 14.82 | 0.12 | 24.62 | 24.76 | 0.15 | |
Brain_Tumor2 | #Acc (%) | 94 | 92.4 | 1.27 | 92 | 91.40 | 0.97 |
#Genes | 4 | 6.0 | 1.83 | 208 | 225.20 | 13.13 | |
#Time | 0.85 | 0.85 | 0.002 | 6 | 6.08 | 0.09 | |
Leukemia1 | #Acc (%) | 100 | 100 | 0 | 100 | 98.75 | 0.44 |
#Genes | 2 | 3.20 | 0.63 | 213.00 | 198.20 | 6.48 | |
#Time | 2.80 | 2.79 | 0.01 | 6.97 | 6.99 | 0.05 | |
Leukemia2 | #Acc (%) | 100 | 100 | 0 | 100 | 100 | 0 |
#Genes | 4 | 6.8 | 2.2 | 195 | 200.80 | 4.24 | |
#Time | 3.1 | 3.1 | 0.02 | 10.05 | 10.16 | 0.15 | |
Lung_Cancer | #Acc (%) | 96.06 | 95.67 | 0.31 | 98.03 | 97.73 | 0.25 |
#Genes | 7 | 8.3 | 2.11 | 212 | 212.90 | 9.26 | |
#Time | 123.95 | 124.08 | 0.49 | 145.98 | 145.93 | 1.00 | |
SRBCT | #Acc (%) | 100 | 99.64 | 0.58 | 100 | 100 | 0 |
#Genes | 7 | 14.90 | 13.03 | 191 | 195.30 | 3.23 | |
#Time | 7.51 | 7.51 | 0.03 | 22.75 | 22.63 | 0.22 | |
Prostate_Tumor | #Acc (%) | 99.02 | 97.84 | 0.62 | 98.04 | 98.04 | 0.00 |
#Genes | 5 | 6.6 | 2.17 | 195 | 199.40 | 3.41 | |
#Time | 4.37 | 4.37 | 0.008 | 22.57 | 22.27 | 0.16 | |
DLBCL | #Acc (%) | 100 | 100 | 0 | 100 | 100 | 0 |
#Genes | 3 | 4.7 | 0.82 | 193 | 200.90 | 3.78 | |
 | #Time | 1.99 | 1.99 | 0.008 | 7.72 | 7.75 | 0.10 |